AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Cash from investing

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-33-181.39%
Mar 31, 202441-110.19%
Mar 31, 2023-403-236.28%
Mar 31, 2022296+50.36%
Mar 31, 2021197-165.52%
Mar 31, 2020-300-62.82%
Mar 31, 2019-807+168.11%
Mar 31, 2018-301-251.74%
Mar 31, 2017198-165.54%
Mar 31, 2016-303+50.84%
Mar 31, 2015-201

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)